Previous studies have confirmed that malic enzyme 2 (ME2), a key enzyme in the tricarboxylic acid (TCA) cycle, is abnormally expressed in some malignant tumors, including melanoma (24), non–small-cell lung cancer (25), and pancreatic cancer (26). This evidence concerns the gene ME2 and cancer.